{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:36:01Z","timestamp":1768005361219,"version":"3.49.0"},"reference-count":29,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Padiatr"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background Antibiotic use during asthma exacerbations in paediatric\n                    patients is not routinely recommended but common practise in out-patient and\n                    in-patient settings. Objective of this study was to analyse frequency of\n                    antibiotic use during acute severe asthma exacerbations, antibiotic classes\n                    utilized and clinical decision-making.<\/jats:p>\n                  <jats:p>Methods All in-patient admissions over 10 years in a single German\n                    Children\u2019s University hospital due to acute severe asthma were included\n                    in this retrospective analysis. Age, length of stay, oxygen supplementation,\n                    treatment, laboratory parameters and chest x-rays of all patients ranging from 1\n                    to 17 years were analysed.<\/jats:p>\n                  <jats:p>Results 580 hospital admissions were included in this study. Overall\n                    antibiotic use was high but decreased with age (1\u20135 years 69,6%,\n                    6\u201311 years 57,6% and 12\u201317 years 39,7%,\n                    p&lt;0.001). Analysis of antibiotic treatment without clear indication\n                    showed a consistently lower treatment rate of 28.3%, with macrolides\n                    being the most common antibiotic class. Younger age significantly decreased,\n                    whereas, increase of CrP value, use of oxygen supplementation and concomitant\n                    fever all significantly increased the odds ratio (OR 0.967; 4.366, 2.472 and\n                    2.011 respectively) of receiving antibiotic treatment without clear\n                    indication.<\/jats:p>\n                  <jats:p>Conclusion Antibiotic treatment without clear indication during acute\n                    severe asthma is common in this German single-centre cohort. Clinical parameters\n                    of more severe disease affect clinician\u2019s decision to administer\n                    antibiotics despite evidence of bacterial infection or improved outcome.<\/jats:p>","DOI":"10.1055\/a-1712-4225","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:05:34Z","timestamp":1647893134000},"page":"277-283","source":"Crossref","is-referenced-by-count":1,"title":["Antibiotic Use in Paediatric Patients Hospitalized with Acute Severe\n                    Asthma"],"prefix":"10.1055","volume":"234","author":[{"given":"Jordis","family":"Trischler","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonology and Cystic fibrosis, Department for\n                    Children and Adolescents, University Hospital Frankfurt, Goethe-University,\n                    Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"von Blumroeder","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonology and Cystic fibrosis, Department for\n                    Children and Adolescents, University Hospital Frankfurt, Goethe-University,\n                    Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Donath","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonology and Cystic fibrosis, Department for\n                    Children and Adolescents, University Hospital Frankfurt, Goethe-University,\n                    Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Kluge","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonology and Cystic fibrosis, Department for\n                    Children and Adolescents, University Hospital Frankfurt, Goethe-University,\n                    Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hutter","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonology and Cystic fibrosis, Department for\n                    Children and Adolescents, University Hospital Frankfurt, Goethe-University,\n                    Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Dre\u00dfler","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonology and Cystic fibrosis, Department for\n                    Children and Adolescents, University Hospital Frankfurt, Goethe-University,\n                    Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Zielen","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonology and Cystic fibrosis, Department for\n                    Children and Adolescents, University Hospital Frankfurt, Goethe-University,\n                    Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00431-017-2913-0","article-title":"A three-step diagnosis of pediatric pneumonia at the emergency department using\n                    clinical predictors, C-reactive protein, and pneumococcal PCR","volume":"176","author":"G Alcoba","year":"2017","journal-title":"Eur J Pediatr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000320319","article-title":"Immunomodulatory effects of macrolide antibiotics - part 1: biological\n                    mechanisms","volume":"81","author":"J Altenburg","year":"2011","journal-title":"Respiration"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e022979","DOI":"10.1136\/bmjopen-2018-022979","article-title":"Antibiotic use in children with asthma: cohort study in UK and Dutch primary\n                    care databases","volume":"8","author":"E J Baan","year":"2018","journal-title":"BMJ Open"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1542\/peds.2009-3068","article-title":"Coprescription of antibiotics and asthma drugs in children","volume":"127","author":"Kde Boeck","year":"2011","journal-title":"Pediatrics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1093\/cid\/ciaa606","article-title":"Reduction of Coronavirus Burden With Mass Azithromycin Distribution","volume":"71","author":"T Doan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"562843","DOI":"10.3389\/fped.2020.562843","article-title":"Hospitalization, Asthma Phenotypes, and Readmission Rates in Pre-school\n                    Asthma","volume":"8","author":"H Donath","year":"2020","journal-title":"Front Pediatr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/02770903.2019.1590590","article-title":"Azithromycin treatment in children hospitalized with asthma: a retrospective\n                    cohort study","volume":"57","author":"L C Douglas","year":"2020","journal-title":"J Asthma"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12890-019-1025-1","article-title":"Asthma and treatment with inhaled corticosteroids: associations with\n                    hospitalisations with pneumonia","volume":"19","author":"E Ekbom","year":"2019","journal-title":"BMC Pulm Med"},{"key":"ref9","first-page":"00944","article-title":"Antibiotic use in children and youths with asthma: a population-based\n                    case-control study","volume":"7 (1)","author":"I Fong","year":"2021","journal-title":"ERJ Open Res"},{"key":"ref10","first-page":"00056","article-title":"Efficacy of azithromycin in severe asthma from the AMAZES randomised trial","volume":"5 (4)","author":"P G Gibson","year":"2019","journal-title":"ERJ Open Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bmjqs-2019-010792","article-title":"Unnecessary antibiotic prescribing in children hospitalised for asthma\n                    exacerbation: a retrospective national cohort study","volume":"30","author":"M J Jewell","year":"2021","journal-title":"BMJ Qual Saf"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa044080","article-title":"The effect of telithromycin in acute exacerbations of asthma","volume":"354","author":"S L Johnston","year":"2006","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/jamainternmed.2016.5664","article-title":"Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical\n                    Trial","volume":"176","author":"S L Johnston","year":"2016","journal-title":"JAMA Intern Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2008.07.029","article-title":"Increased risk of serious pneumococcal disease in patients with asthma","volume":"122","author":"Y J Juhn","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00006454-200205000-00004","article-title":"Correlation between serum interleukin 6 and C-reactive protein concentrations in\n                    patients with adenoviral respiratory infection","volume":"21","author":"Y Kawasaki","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1542\/peds.2005-2443","article-title":"Antibiotic treatment of wheezing in children with asthma: what is the\n                    practice?","volume":"117","author":"A L Kozyrskyj","year":"2006","journal-title":"Pediatrics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1515\/cclm-2019-0194","article-title":"A high C-reactive protein\/procalcitonin ratio predicts Mycoplasma\n                    pneumoniae infection","volume":"57","author":"O L Neeser","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"ref18","first-page":"CD002741","article-title":"Antibiotics for exacerbations of asthma","volume":"6","author":"R Normansell","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1159\/000507857","article-title":"Recent Practice Patterns and Variations in Children Hospitalized for Asthma\n                    Exacerbation in Japan","volume":"181","author":"Y Okubo","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/000992288802701104","article-title":"Serious bacterial infections. C-reactive protein as a serial index of\n                    severity","volume":"27","author":"H Peltola","year":"1988","journal-title":"Clin Pediatr (Phila)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"106494","DOI":"10.1016\/j.rmed.2021.106494","article-title":"Effect of azithromycin on bronchial wall thickness in severe persistent asthma:\n                    A double-blind placebo-controlled randomized clinical trial","volume":"185","author":"M Sadeghdoust","year":"2021","journal-title":"Respir Med"},{"key":"ref22","first-page":"00593","article-title":"Emergency department visits and hospitalisations for asthma, COPD and\n                    respiratory tract infections: what is the role of respiratory viruses, and\n                    return to school in September, January and March?","volume":"6(4)","author":"I Satia","year":"2020","journal-title":"ERJ Open Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1183\/09031936.00102014","article-title":"Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial\n                    cells","volume":"45","author":"A Sch\u00f6gler","year":"2015","journal-title":"Eur Respir J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/421997","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial\n                    infection: a systematic review and meta-analysis","volume":"39","author":"L Simon","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref25","first-page":"1","article-title":"Uncertainty as a critical determinant of antibiotic prescribing in patients with\n                    an asthma exacerbation: a qualitative study","author":"M S Stefan","year":"2020","journal-title":"J Asthma"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-2600(15)00500-7","article-title":"Azithromycin for episodes with asthma-like symptoms in young children aged 1-3\n                    years: a randomised, double-blind, placebo-controlled trial","volume":"4","author":"J Stokholm","year":"2016","journal-title":"Lancet Respir Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1056\/NEJMoa044113","article-title":"Asthma as a risk factor for invasive pneumococcal disease","volume":"352","author":"T R Talbot","year":"2005","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1553-2712.2008.00167.x","article-title":"Inappropriate use of antibiotics for acute asthma in United States emergency\n                    departments","volume":"15","author":"S G Vanderweil","year":"2008","journal-title":"Acad Emerg Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijantimicag.2018.12.009","article-title":"Spiramycin and azithromycin, safe for administration to children, exert\n                    antiviral activity against enterovirus A71 in vitro and in vivo","volume":"53","author":"S Zeng","year":"2019","journal-title":"Int J Antimicrob Agents"}],"container-title":["Klinische P\u00e4diatrie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1712-4225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:30:58Z","timestamp":1764102658000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1712-4225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":29,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2022,9,21]]},"published-print":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1712-4225","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0300-8630","1439-3824"],"issn-type":[{"value":"0300-8630","type":"print"},{"value":"1439-3824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]}}}